Disparities in Refusal of Locoregional Treatment for Prostate Adenocarcinoma.

LT refusal has increased over time; racial disparities were greater in higher-risk disease. Refusal despite provider recommendation highlights populations that may benefit from efforts to assess and reduce barriers to care.